Apple’s Healthcare Ambitions Just Took a Leap Forward: Time to Buy?

Apple (NASDAQ: AAPL) has received a barrage of bad news since the start of the year. The company’s iPhone sales in China — one of its most important international markets — have been struggling, its overall financial results haven’t been great, and it’s being sued by the U.S. D

admin